Andrew Yee, MD

• Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

  Phase 2, Active, not recruiting, 44 people, Nov 25, 2019

• NCT04119336

  Phase 2, Terminated, 2 people, Oct 8, 2019

Sources: clinicaltrials.gov